The Rising Threat of Xylazine in Michigan
Xylazine use is on the rise, particularly in the Midwest, where overdose cases involving the drug have increased by 500% in recent years, according to the Office of National Drug Control Policy.
Henry Ford + MSU Researchers Collaborate to Shift Pancreatic Cancer Outlook From Bleak to Bright
Henry Ford Health and MSU researchers are teaming up to change the outlook for pancreatic cancer patients.
Rx Kids Celebrates Program’s First Birthday, Shares Milestones
More than 1,300 babies and families in the city of Flint have received nearly $6 million in cash prescriptions since Rx Kids launched in January 2024.
What’s New in the Treatment of Sickle Cell Disease?
Discover the latest advancements in sickle cell disease (SCD) treatment from MSU Health Care expert Dr. Shawn Jobe. Learn about new gene therapies, common challenges SCD patients face, and how MSU’s Sickle Cell Disease Lifespan Clinic supports patients transitioning to adult care.
Recent Grad Saves Patient's Life After Suspected Overdose
Recent MSU College of Nursing graduate Marco Muñoz, BSN ’24, saved a patient’s life at a Detroit hospital using Narcan.
New Clinical Agreement Furthers Michigan State University and Henry Ford Health Partnership
Michigan State University and Henry Ford Health solidify a 30-year partnership with a new master services agreement, enhancing patient care, clinical integration, and healthcare innovation across Michigan.
